Photos of university / #ucl
Cardiovascular diseases remain a major cause of death and ill health worldwide. This established MSc programme, taught by scientists and clinicians who are leaders in their field, offers students the opportunity to learn about topical areas in cardiovascular science, preparing them for further research or a career in industry.
Core modules
- Cardiovascular Diseases
- Animal Models of Cardiovascular Disease
- Congenital Heart Disease - Fundamentals
- Heart and Circulation (30 credits)
- Basic Statistics for Medical Science
Optional modules
30 credits of optional modules drawn from the following:
- Genetics of Cardiovascular Disease
- Clinical Application of Pharmacogenetic Test
- Drug Discovery II
- Microvascular Biology
- An introduction to Molecular Laboratory Methods in Cardiovascular Research
- Clinical Cardiology (open to clinicians only)
Clinical Cardiology is an academic MSc module rather than a standard clinical placement. The emphasis is to appreciate the impact of advances in cardiovascular science upon clinical practice.
Dissertation/research project
All MSc students undertake an independent research project which culminates in a dissertation of 10,000-12,000 words and an oral presentation (60 credits).
Teaching and learning
The programme is delivered through a combination of lectures, seminars, presentations, tutorials, journal clubs, a quiz, statistical and laboratory practicals and anatomical examination of human congenital heart disease specimens. Assessment is through written and oral examinations, coursework essays, case reports, journal club and other oral presentations and the dissertation.
- 5 year Specialist Diploma with an overall mark of 4.5/5.0
- Bachelor's degree with an overall mark of 4.5/5.0
- Test of English as a Foreign Language (TOEFL). Score of 92 overall
- British Council International Language Testing System (IELTS Academic Version). Overall grade of 6.5
Funding options for the Cardiovascular Science MSc at University College London include a range of scholarships, bursaries, and financial aid opportunities. Prospective students are encouraged to explore university-wide funding schemes such as UCL Graduate Scholarships, which are awarded based on academic excellence and potential. Additionally, UCL offers specific scholarships for international students, including the Overseas Research Scholarships and the Commonwealth Scholarships, which can offset tuition fees and living costs. Students are also advised to investigate external funding sources, such as government-funded loans and private scholarships from health foundations and cardiovascular research charities. The UK Research and Innovation (UKRI) and the British Heart Foundation (BHF) provide funding opportunities for postgraduate research students engaged in cardiovascular topics, often supporting projects aligned with their strategic priorities. Applicants are recommended to contact UCL’s Student Funding Office and the Programme Directors to receive tailored advice about eligibility, application procedures, and deadlines. Moreover, many students finance their studies through part-time work or teaching assistant roles offered within the university. The cost of tuition varies depending on residency status; UK/EU students usually benefit from lower tuition fees compared to international students. Living expenses in London should also be considered, with estimates including accommodation, transportation, food, and personal costs. UCL provides guidance and workshops on budgeting and financial planning to help students manage their finances effectively throughout their studies. Prospective students are encouraged to start their search for funding early and carefully review all eligibility criteria to maximize their chances of securing financial support. Overall, while tuition costs and living expenses represent a significant investment, numerous funding opportunities are available to help offset these costs and make the MSc in Cardiovascular Science accessible to talented students from diverse backgrounds.
The MSc in Cardiovascular Science at University College London (UCL) is a comprehensive postgraduate program designed to provide students with an in-depth understanding of the fundamental and applied aspects of cardiovascular biology, disease mechanisms, and therapeutic approaches. This program aims to equip students with the necessary skills to pursue careers in research, clinical practice, or industry related to cardiovascular health. The curriculum integrates lectures, seminars, practical laboratory sessions, and independent research projects, fostering a multidisciplinary approach to cardiovascular science. Students will explore topics such as coronary artery disease, heart failure, hypertension, atherosclerosis, arrhythmias, and the development of novel diagnostic tools and treatments. UCL's strong links with leading hospitals and research institutes provide students with unique opportunities to engage in cutting-edge research and clinical collaboration. The program also emphasizes the importance of experimental techniques, data analysis, and scientific communication, preparing graduates for roles in academia, biotechnology, pharmaceuticals, or healthcare. Assessment methods include written exams, coursework, presentations, and research dissertations. Graduates of the MSc in Cardiovascular Science will be well-positioned to contribute to advancements in understanding and treating cardiovascular diseases, which remain the leading cause of death worldwide. The program's faculty comprises internationally recognized experts committed to mentoring students and fostering a vibrant research environment. This MSc program typically lasts one year full-time or two years part-time, offering flexibility for working professionals. Applicants are expected to have a relevant undergraduate degree, such as in biomedical sciences, medicine, or related fields. Overall, the MSc in Cardiovascular Science at UCL combines academic excellence, research innovation, and practical training to prepare students for a successful career in cardiovascular research and healthcare.